Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

12.5%

2 terminated/withdrawn out of 16 trials

Success Rate

86.7%

+0.2% vs industry average

Late-Stage Pipeline

38%

6 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 4

4(36.4%)

Phase 3

2(18.2%)

Phase 2

2(18.2%)

N/A

2(18.2%)

Phase 1

1(9.1%)

11Total

Phase 4(4)

Phase 3(2)

Phase 2(2)

N/A(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials

NCT05324358Phase 3Suspended

Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy

Role: collaborator

NCT04320940Phase 3Terminated

Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures

Role: lead

NCT03044522Not ApplicableCompleted

Use of a Nurse Pain Educator for Patients With Chronic Pain

Role: lead

NCT01517295Phase 4Completed

Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients

Role: lead

NCT00414596Phase 2Completed

Pilot Study to Evaluate The Effectiveness And Safety Of Axiom Worldwide Drx9000™ Spinal Decompression System

Role: lead

NCT00469118Phase 2Withdrawn

Clinical Efficacy and Safety of Axiom Worldwide DRX9000 Axial Decompression System for Treatment of Low Back Pain

Role: lead

NCT01177241Completed

Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids

Role: lead

NCT01177254Completed

Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions

Role: lead

NCT01177280Completed

Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes

Role: lead

NCT01177267Completed

Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions(DDI) Among Osteoarthritis Patients

Role: lead

NCT01387750Phase 1Completed

Mentholated Cream Containing Oxygenated Glycerol Triesters on Acute Pain of the Muscles and Joints

Role: lead

NCT00741962Not ApplicableCompleted

A Study on the Effects of VR-3 Herbal Blend Intake on Acute and Chronic Stress in Healthy Adults

Role: lead

NCT00828880Completed

Restoration of Disc Height Reduces Chronic Low Back Pain

Role: lead

NCT00380965Phase 4Completed

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy

Role: lead

NCT00380913Phase 4Completed

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy

Role: lead

NCT00381264Phase 4Completed

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis

Role: lead

All 16 trials loaded